ESCALON MEDICAL CORP | |||||||||||||||||||||||||||||||||||||||||||||||||
Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
Balance Sheet Date | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 | ||
Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | ||
Price to Sales | |||||||||||||||||||||||||||||||||||||||||||||||||
Forward Price to Sales MRQ | |||||||||||||||||||||||||||||||||||||||||||||||||
Price to Book | |||||||||||||||||||||||||||||||||||||||||||||||||
Price to Earnings | |||||||||||||||||||||||||||||||||||||||||||||||||
Forward Price to Earnings MRQ | |||||||||||||||||||||||||||||||||||||||||||||||||
Debt to Asset Ratio | .62x | .56x | .55x | .62x | .62x | .64x | .61x | .61x | .64x | .66x | .75x | .77x | .71x | .72x | .67x | .67x | .74x | .77x | .75x | .77x | .74x | .64x | .63x | .54x | .58x | .58x | .59x | .57x | .56x | .57x | .68x | .78x | .76x | .73x | .74x | .70x | .65x | .58x | .57x | .55x | .54x | .56x | .56x | .56x | .55x | .49x | .50x | ||
Current Ratio | 1.72x | 1.92x | 1.95x | 1.66x | 1.65x | 1.58x | 1.64x | 1.66x | 1.63x | 1.57x | 1.29x | 1.27x | 1.39x | 1.40x | 1.52x | 1.53x | 1.35x | 1.31x | 1.44x | 1.39x | 1.51x | 1.58x | 1.60x | 1.71x | 1.89x | 1.92x | 1.88x | 1.99x | 2.04x | 2.00x | 1.56x | 1.34x | 1.38x | 1.42x | 1.40x | 1.49x | 1.63x | 2.00x | 1.99x | 2.08x | 2.09x | 2.00x | 2.02x | 2.01x | 2.06x | 2.37x | 2.35x |